Literature DB >> 36213478

Assessment of Occult Nodal Micrometastases to the Clinically Negative Contralateral Neck in Locally Advanced Supraglottic Squamous Cell Carcinoma.

Ahmad Mohamed Eltelety1, Mohamed Aly Abou-Zeid1, Mena Esmat Abdelmalek1, Ahmed Amin Nassar1.   

Abstract

The aim of this study is  to study the incidence of occult nodal micrometastases (ONM) in the contralateral neck and compare it to the laterality of the primary tumor. Retrospective analysis of the medical records of patients with locally advanced supraglottic squamous cell carcinoma and Clinically negative contralateral neck (cN0-CLN) - who had concurrent total laryngectomy and bilateral neck dissection as their primary treatment at the Otolaryngology Department, Al Kas Al Ainy School of Medicine-Cairo University between 2015 and 2020 - was conducted. Patients were divided into 3 groups according to the extent of the primary tumor. 28 patients met the inclusion criteria. Patients with well-lateralized tumors were 14 (Group A), tumors abutting the midline were 4 (Group B) and tumors significantly involving the contralateral side were 14 (Group C). There was no statistically significant difference in age of patients among the three groups. Eleven patients had cervical lymphadenopathy in the final pathology reports. Seven patients had ONM, all of whom were among group C patients (7/14; 50%). The degree of tumor differentiation was not associated with the presence of ONM. Treatment of the cN0-CLN is justified in locally advance supraglottic carcinoma significantly crossing the midline. The total number of patients with ONM in the cN0-CLN exceeds the threshold for observation, however the authors could not recommend or refute the practice of routine prophylactic treatment of the cN0-CLN as none of the patients-in this study-with well-lateralized tumors or tumors just abutting the midline showed ONM. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  Clinically negative; Contralateral neck; Micrometastases; Squamous cell carcinoma; Supraglottis

Year:  2021        PMID: 36213478      PMCID: PMC9535062          DOI: 10.1007/s12070-021-02806-3

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  27 in total

1.  The extent of neck disease after regional failure during observation of the N0 neck.

Authors:  P E Andersen; E Cambronero; A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1996-12       Impact factor: 2.565

2.  Supraglottic laryngeal cancer: analysis of treatment results.

Authors:  Donald G Sessions; Jason Lenox; Gershon J Spector
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

3.  Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.

Authors:  Ye Zhang; Siyuan Xu; Wensheng Liu; Xiaolei Wang; Kai Wang; Shaoyan Liu; Zhengang Xu; Jie Liu
Journal:  Head Neck       Date:  2019-11-14       Impact factor: 3.147

Review 4.  Overview of the 8th Edition TNM Classification for Head and Neck Cancer.

Authors:  Shao Hui Huang; Brian O'Sullivan
Journal:  Curr Treat Options Oncol       Date:  2017-07

5.  Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.

Authors:  Andrew W Smith; Matthew Gallitto; Eric J Lehrer; Isaac Wasserman; Vishal Gupta; Sonam Sharma; Jerry T Liu; Marshall Posner; Krzysztof Misiukiewicz; William H Westra; Eric M Genden; Yarah Haidar; Mike Yao; Marita S Teng; Brett A Miles; Richard L Bakst
Journal:  Head Neck       Date:  2021-01-21       Impact factor: 3.147

Review 6.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07

7.  The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications.

Authors:  Luca O Redaelli de Zinis; Piero Nicolai; Davide Tomenzoli; Daniela Ghizzardi; Matteo Trimarchi; Johnny Cappiello; Giorgio Peretti; Antonino R Antonelli
Journal:  Head Neck       Date:  2002-10       Impact factor: 3.147

8.  Is routine bilateral neck dissection absolutely necessary in the management of N0 neck in patients with supraglottic carcinoma?

Authors:  S Cağli; I Yüce; O G Yiğitbaşi; E Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-12       Impact factor: 2.503

9.  Rate of Occult Cervical Lymph Node Involvement in Supraglottic Squamous Cell Carcinoma.

Authors:  Maziar Motiee Langroudi; Behrooz Amirzargar; Amin Amali; Mohammad Sadeghi; Mehrdad Jafar; Mohammad Reza Hoseini; Fatemeh Tavakolnejad
Journal:  Iran J Otorhinolaryngol       Date:  2017-05

Review 10.  Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management.

Authors:  Mauricio E Gamez; Adriana Blakaj; Wesley Zoller; Marcelo Bonomi; Dukagjin M Blakaj
Journal:  Cancers (Basel)       Date:  2020-06-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.